Manejo de toxicidades por inmunoterapias
Prost, Diego M; Cinat, Gabriela.
Oncol. clín
; 22(2): 46-51, 2017.
Artículo en Español | LILACS | ID: biblio-882464
Documentos relacionados
Differences between immunotherapy-induced and primary hypophysitis-a multicenter retrospective study.
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.
[Immunotherapy-associated panhypophysitis].
Endocrine complications of immunotherapies: a review.
How we treat endocrine complications of immune checkpoint inhibitors.
The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients.
Immune checkpoint inhibitor-induced hypophysitis: clinical and biochemical features.
Thyroid disorders induced by checkpoint inhibitors.
Cancer immunotherapy-associated hypophysitis.
Novel Cellular and Immunotherapy: Toxicities and Perioperative Implications.